We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+9.02%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.27B
AUM Growth
+$957K
Cap. Flow
-$81.4M
Cap. Flow %
-6.43%
Top 10 Hldgs %
5.55%
Holding
1,966
New
431
Increased
565
Reduced
590
Closed
359

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$7.23M
2
LNKD
LinkedIn Corporation
LNKD
+$7.08M
3
PFE icon
Pfizer
PFE
+$6.7M
4
BBY icon
Best Buy
BBY
+$6.21M
5
PCYC
PHARMACYCLICS INC
PCYC
+$6.09M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$12.3M
2
HPQ icon
HP
HPQ
+$8.76M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.48M
4
BAX icon
Baxter International
BAX
+$6.78M
5
MPC icon
Marathon Petroleum
MPC
+$6.75M

Sector Composition

Rank Sector Weight
1 Industrials 12.7%
2 Healthcare 12.7%
3 Consumer Discretionary 11.82%
4 Technology 11.74%
5 Financials 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XCO
451
DELISTED
Exco Resources
XCO
$872K 0.07%
10,950
-2,179
-17% -$186K
MRK icon
452
Merck
MRK
$316B
$870K 0.07%
18,208
-35,923
-66% -$1.64M
CNC icon
453
Centene
CNC
$31.5B
$869K 0.07%
+58,944
New +$881K
BWXT icon
454
BWX Technologies
BWXT
$15.9B
$866K 0.07%
35,407
+4,949
+16% +$116K
NWSA icon
455
News Corp Class A
NWSA
$15.1B
$865K 0.07%
+47,981
New +$828K
ROST icon
456
Ross Stores
ROST
$81.1B
$865K 0.07%
+23,078
New +$867K
AMGN icon
457
Amgen
AMGN
$204B
$862K 0.07%
7,552
-38,082
-83% -$4.33M
ARCC icon
458
Ares Capital
ARCC
$13.8B
$860K 0.07%
48,400
+23,000
+91% +$405K
FTI icon
459
TechnipFMC
FTI
$27.1B
$860K 0.07%
22,149
+15,844
+251% +$615K
VRA icon
460
Vera Bradley
VRA
$99.2M
$857K 0.07%
35,644
-4,646
-12% -$106K
DK icon
461
Delek US
DK
$4.05B
$856K 0.07%
24,865
-38,299
-61% -$1.04M
OMC icon
462
Omnicom Group
OMC
$21.7B
$855K 0.07%
11,500
-35,590
-76% -$2.45M
TOWR
463
DELISTED
Tower International, Inc.
TOWR
$854K 0.07%
39,894
+10,064
+34% +$210K
BTU
464
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$854K 0.07%
2,916
-229
-7% -$64.6K
BALL icon
465
Ball Corp
BALL
$17.3B
$853K 0.07%
+33,036
New +$806K
CELG
466
DELISTED
Celgene Corp
CELG
$852K 0.07%
10,086
-11,556
-53% -$914K
EEFT icon
467
Euronet Worldwide
EEFT
$2.8B
$850K 0.07%
17,755
+4,702
+36% +$211K
IM
468
DELISTED
Ingram Micro
IM
$850K 0.07%
36,234
+26,662
+279% +$625K
CMP icon
469
Compass Minerals
CMP
$1.21B
$849K 0.07%
10,610
+1,652
+18% +$124K
ATHN
470
DELISTED
Athenahealth, Inc.
ATHN
$848K 0.07%
6,307
+3,105
+97% +$399K
SANM icon
471
Sanmina
SANM
$10.4B
$847K 0.07%
50,728
-18,883
-27% -$304K
AMCX icon
472
AMC Global Media
AMCX
$479M
$846K 0.07%
12,420
+1,829
+17% +$122K
DXCM icon
473
DexCom
DXCM
$32.9B
$845K 0.07%
+95,468
New +$756K
AXLL
474
DELISTED
AXIALL CORP COM STK (DE)
AXLL
$843K 0.07%
17,769
+9,277
+109% +$399K
MCD icon
475
McDonald's
MCD
$188B
$839K 0.07%
8,651
+2,290
+36% +$220K
17 18
19
20 21

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's Q4 2013 Portfolio in Review

As of Q4 2013, GSA Capital Partners held 1,966 positions worth $1.27B, up 0.08% from $1.26B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

GSA Capital Partners withdrew a net $81.4M in Q4 2013, closing 359 positions and reducing 590 holdings. Its most notable exit was CVS Health, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, GSA Capital Partners opened a new position in Pfizer worth $6.69M.

  • GSA Capital Partners's largest Q4 2013 buy was Pfizer: 230,320 shares worth $6.69M.
  • GSA Capital Partners added most to CME Group in Q4 2013, an estimated $7.23M increase.
  • GSA Capital Partners's biggest Q4 2013 reduction was HP, cutting an estimated $8.76M.
  • GSA Capital Partners fully exited CVS Health in Q4 2013, selling an estimated $12.3M.
  • GSA Capital Partners's ten largest holdings make up 5.6% of its $1.27B portfolio in Q4 2013.
  • GSA Capital Partners opened 431 new positions and closed 359 in Q4 2013.
  • GSA Capital Partners's portfolio value rose 0.08% quarter-over-quarter to $1.27B.

Based on GSA Capital Partners's 13F filing for Q4 2013, filed 12 Feb 2014.